Delos Capital logo

Delos Capital

North America, New York, United States, New York

Description

Delos Capital is a lower-middle market private equity investment firm.

Investor Profile

Delos Capital has made 25 investments, with 5 in the past 12 months and 32% as lead.

Stage Focus

  • Series B (28%)
  • Series A (24%)
  • Series C (20%)
  • Private Equity (12%)
  • Series D (8%)
  • Debt Financing (4%)
  • Series E (4%)

Country Focus

  • United States (92%)
  • Germany (4%)
  • Canada (4%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Pharmaceutical
  • Therapeutics
  • Oncology
  • Health Diagnostics
  • Manufacturing
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Delos Capital frequently co-invest with?

Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 4
SG
North America, Massachusetts, United States, Stoneham
Co-Investments: 3
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 6
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 3
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 4
Longitude Capital
North America, California, United States, Menlo Park
Co-Investments: 3
Ascension Ventures
North America, Missouri, United States, Clarkton
Co-Investments: 4
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 3
Quan Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 3
AV
North America, California, United States, San Francisco
Co-Investments: 3

Which angels does Delos Capital often collaborate with?

NB
Europe, Basel-Stadt, Switzerland, Basel
Shared Deals: 1
RD
North America, New York, United States
Shared Deals: 1

What are some of recent deals done by Delos Capital?

Avenzo Therapeutics

San Diego, California, United States

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series ANov 18, 2024
Alpha9 Theranostics

Vancouver, British Columbia, Canada

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

BiotechnologyMedicalProduct Research
Series COct 23, 2024
Amount Raised: $175,000,000
Cardurion Pharmaceuticals

Boston, Massachusetts, United States

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series BJul 16, 2024
Amount Raised: $260,000,000
AltruBio

Los Altos, California, United States

AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.

BiotechnologyHealth CareMedical
Series BMay 21, 2024
Amount Raised: $225,000,000
Zenas BioPharma

Waltham, Massachusetts, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

BiopharmaHealth CarePharmaceutical
Series CMay 7, 2024
Amount Raised: $200,000,000
Avenzo Therapeutics

San Diego, California, United States

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series AMar 26, 2024
Amount Raised: $150,000,000
Instylla

Waltham, Massachusetts, United States

Instylla is a medical equipment supplier that provides liquid embolics of the next generation for interventional radiology.

BiotechnologyCommercialMedical Device
Series CAug 15, 2023
Amount Raised: $30,000,000
Ensoma

Boston, Massachusetts, United States

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

BiotechnologyGeneticsLife ScienceMedicalOncologyTherapeutics
Series BMay 16, 2023
Amount Raised: $50,000,000
Rejoni

Bedford, Massachusetts, United States

Rejoni develops solutions designed to minimize the short and long-term risks associated with gynecological procedures.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series BDec 7, 2022
Amount Raised: $26,250,000
Rgenta Therapeutics

Cambridge, Massachusetts, United States

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

BiotechnologyHealth CareMedicalOncologyPharmaceuticalTherapeutics
Series ANov 29, 2022
Amount Raised: $52,000,000